Novel EWSR1::TEAD3 Fusion in an Adolescent With a Highly Aggressive Peritoneal Mesothelioma

Qixing Gong1, Jia Wei2, Sheng Xiao3,4

  • 1Department of Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Genes, Chromosomes & Cancer
|February 19, 2026
PubMed

Insights

Pediatric malignant peritoneal mesothelioma is rare and lacks asbestos links. This report details an 18-year-old male with a novel EWSR1::TEAD3 gene fusion, advancing understanding of this rare cancer.

Area of Science:

  • Oncology
  • Genetics
  • Pathology

Background:

  • Malignant peritoneal mesothelioma (MPM) is rare in pediatric patients, differing from adult cases by lacking asbestos exposure history or BAP1 mutations.
  • The oncogenic drivers and molecular pathways in pediatric MPM remain largely unknown, despite identified gene fusions.

Purpose of the Study:

  • To report a unique case of MPM in an adolescent.
  • To identify the molecular underpinnings of this rare pediatric malignancy.

Main Methods:

  • Clinical presentation and imaging (CT scan) were analyzed.
  • Histopathological and immunohistochemical analyses were performed.
  • Molecular genetic studies identified a novel gene fusion.

Main Results:

  • An 18-year-old male presented with ascites and abdominal distension.
  • Histopathology confirmed biphasic mesothelioma.
  • A novel EWSR1::TEAD3 gene fusion was identified in the tumor.

Conclusions:

  • This is the first reported case of peritoneal mesothelioma with an EWSR1::TEAD3 gene fusion.
  • The findings contribute to understanding the molecular landscape of pediatric MPM.